This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Synovus Shares Gains as Q3 Earnings Top Estimates on Higher NIR
by Zacks Equity Research
SNV's third-quarter results benefit from an increase in non-interest income and a decline in expenses. A dip in NII acted as a spoilsport.
M&T Bank Q3 Earnings Surpass Estimates on Y/Y Rise in Fee Income
by Zacks Equity Research
MTB's third-quarter 2024 results benefit from increased non-interest income and loans. A decline in NII acts as a spoilsport.
Synovus (SNV) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Synovus (SNV) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Synovus Financial (SNV) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Synovus (SNV) delivered earnings and revenue surprises of 12.84% and 1.34%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Curious about Synovus (SNV) Q3 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Synovus (SNV) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
F.N.B. (FNB) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
F.N.B. (FNB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Synovus Financial (SNV) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Synovus (SNV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FITB Gives Q3 Update, Commercial Payment to Reach $1B in 5 Years
by Zacks Equity Research
Fifth Third updates its third-quarter 2024 guidance while focusing on enhancing its commercial payment platform through strategic partnerships.
Huntington's Strategic Initiatives Look Promising: Is the Stock a Buy?
by Zacks Equity Research
HBAN is progressing well with its strategic initiatives to expand into high-growth markets to boost its loans and deposit balances.
Synovus Stock Falls 2.1%, Fed Rate Cut to Hurt Q3 NII Growth
by Zacks Equity Research
SNV provides its third-quarter 2024 outlook. NII is expected to be impacted by the muted loan growth environment and the impact of expected Federal Reserve rate cuts.
Synovus (SNV) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Synovus (SNV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
5 Reasons to Add Synovus (SNV) Stock to Your Portfolio Now
by Zacks Equity Research
Synovus (SNV) is well poised to gain from strategic mergers and acquisitions and balance sheet strength.
Why Is Synovus (SNV) Down 4.7% Since Last Earnings Report?
by Zacks Equity Research
Synovus (SNV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Synovus (SNV) Thrives on Organic Growth Amid High Costs
by Zacks Equity Research
Synovus (SNV) continues to benefit from strong loans and deposit balances. Balance sheet strength and strong liquidity position is another positive.
Synovus Financial (SNV) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Synovus Financial (SNV) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is First Trust SMID Cap Rising Dividend Achievers ETF (SDVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SDVY
Capital One (COF) Q2 Earnings Miss on Y/Y Increase in Provisions
by Zacks Equity Research
Capital One (COF) records y/y increases in revenues and expenses in the second quarter of 2024.
Synovus (SNV) Q2 Earnings Beat Estimates, Revenues Fall Y/Y
by Zacks Equity Research
Synovus' (SNV) Q2 earnings benefit from a year-over-year decline in expenses and provisions. However, declining loan and deposit balances, along with lower NII, act as spoilsports.
Synovus (SNV) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Synovus (SNV) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Synovus Financial (SNV) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Synovus (SNV) delivered earnings and revenue surprises of 20.83% and 38.35%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
What Makes Synovus Financial (SNV) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Synovus Financial (SNV) have what it takes to be a top stock pick for momentum investors? Let's find out.
Ahead of Synovus (SNV) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Synovus (SNV) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Earnings Preview: Investar (ISTR) Q2 Earnings Expected to Decline
by Zacks Equity Research
Investar (ISTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Synovus Financial (SNV) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Synovus (SNV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Synovus' (SNV) Organic Expansion Drives Growth, High Costs Ail
by Zacks Equity Research
Synovus (SNV) benefits from the strategic expansion efforts of its banking verticals. However, a rise in expenses is likely to impede bottom-line growth in the near term.